CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
Age and incidence of residual neuromuscular blockadeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01545193
NCT01545193N/ACompleted

The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade

Endeavor Health·observational·Posted Mar 6, 2012·Updated Sep 16, 2019

In Brief

An observational study evaluating Age and incidence of residual neuromuscular blockade for Residual Neuromuscular Blockade in Elderly Patients. Completed, enrolled 300 participants across 1 site.

Detailed Summary

Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is uncertain whether certain patient populations are at greater risk for this common anesthetic complication. However, it is possible that elderly surgical patients may exhibit a higher incidence of residual neuromuscular blockade. The aim of this clinical trial is to determine the incidence of residual neuromuscular blockade in a cohort of younger (ages 18-50) and older (ages 70-90) patients undergoing surgery and general anesthesia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 6, 2012
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2013
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.3 years ago

Interventions

Age and incidence of residual neuromuscular blockadeother

An older cohort is anticipated to have a higher incidence of residual neuromuscular blockade